We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia

Product News   Dec 10, 2019

 
Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia
FURTHER INFORMATION
 
 
 

Related Product News

TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-concept

Product News

Avacta, the developer of Affimer® biotherapeutics and reagents, has announced that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate.

READ MORE

ProBioGen and Lava Therapeutics Sign Development and Manufacturing Agreement for Novel Bispecific Molecule

Product News

ProBioGen and Lava Therapeutics have announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.

READ MORE

Horizon Discovery and Mammoth Biosciences Collaborate To Improve Biotherapeutic Production

Product News

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE